| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/24/2004 | CA2507400A1 Lna-cpg conjugates |
| 06/24/2004 | CA2507141A1 Optimized protein synthesis |
| 06/24/2004 | CA2504357A1 Antisense modulation of mitoneet expression |
| 06/24/2004 | CA2502428A1 Expression cassette encoding a 5-enolpyruvylshikimate-3-phosphate synthase (epsps) and herbicide-tolerant plants containing it |
| 06/24/2004 | CA2502424A1 Fertile transplastomic soybean plants |
| 06/24/2004 | CA2502015A1 5' cpg nucleic acids and methods of use |
| 06/23/2004 | EP1431401A2 Method for detecting and/or quantifying a known function from a nucleic acid sample |
| 06/23/2004 | EP1431400A2 Method of detecting acid-fast bacteria using ribosomal RNA as target |
| 06/23/2004 | EP1431397A1 Method for measuring UDP-GlcNAc |
| 06/23/2004 | EP1431396A1 Method for measuring glucosamine-6-phosphate |
| 06/23/2004 | EP1431394A1 Method to produce heterologous glycosylated proteins in bryophyte cells |
| 06/23/2004 | EP1431393A1 Plants synthesising starch with increased viscosity |
| 06/23/2004 | EP1431392A1 PLANT SYSTEM FOR COMPREHENSIVE GENE FUNCTION ANALYSIS WITH THE USE OF FULL-LENGTH cDNA |
| 06/23/2004 | EP1431391A2 Rantes mutants and therapeutic applications thereof |
| 06/23/2004 | EP1431390A1 Sample processing device and sample processing method |
| 06/23/2004 | EP1431389A2 Cellulase variants |
| 06/23/2004 | EP1431388A2 A method for direct cloning of nuclease genes in E.Coli |
| 06/23/2004 | EP1431387A1 Heat-labile desoxyribonculease I variants |
| 06/23/2004 | EP1431310A1 RECOMBINANT ANTI−OSTEOPONTIN ANTIBODY AND USE THEREOF |
| 06/23/2004 | EP1431307A1 Inactive transcription factor TIF-IA and uses thereof |
| 06/23/2004 | EP1431303A2 Composition for linear isothermal amplification of polynucleotide sequences |
| 06/23/2004 | EP1431298A1 Mannitol and glucitol derivatives |
| 06/23/2004 | EP1430902A1 Pharmaceutical composition of interferon gamma with molecular diagnostics for the improved treatment of asthma bronchiale |
| 06/23/2004 | EP1430462A1 Printed materials comprising a support having an oligomer and/or a polymer applied thereon, a method for preparing the same and a method for delivering and/or storing the same |
| 06/23/2004 | EP1430436A2 Methods for determining protein and peptide terminal sequences |
| 06/23/2004 | EP1430304A1 Method and agent for diagnosing and treating chronic inflammatory bowel diseases |
| 06/23/2004 | EP1430301A2 Method for producing a normalized gene library from nucleic acid extracts of soil samples and the use thereof |
| 06/23/2004 | EP1430157A2 RNA INTERFERENCE MEDIATED INHIBITION OF HEPATITIS C VIRUS (HCV) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 06/23/2004 | EP1430156A2 Nucleic acid sequencing by raman monitoring of uptake of precursors during molecular replication |
| 06/23/2004 | EP1430153A2 Methods for detecting genetic mosaicisms using arrays |
| 06/23/2004 | EP1430152A2 Gene and protein relating to hepatocellular carcinoma |
| 06/23/2004 | EP1430151A1 Brain expressed cap-2 gene and protein associated with bipolar disorder |
| 06/23/2004 | EP1430150A2 Diagnostic probe detection system |
| 06/23/2004 | EP1430149A2 Nucleid acid sequencing by raman monitoring of molecular deconstruction |
| 06/23/2004 | EP1430145A2 Methods and kits for determing a risk to develop cancer, for evaluating an effectiveness and dosage of cancer therapy and for correlating between an activity of a dna repair enzyme and a cancer |
| 06/23/2004 | EP1430144A2 METHODS OF USING 69039, A NOVEL HUMAN Na/Ca EXCHANGER FAMILY MEMBER |
| 06/23/2004 | EP1430140A2 Isoform-selective inhibitors and activators of pde3 cyclic |
| 06/23/2004 | EP1430139A2 Process for the preparation of d-pantothenic acid and/or its salts |
| 06/23/2004 | EP1430137A2 Porcine adenovirus e1 and e4 regions |
| 06/23/2004 | EP1430136A1 Muteins of apolipoprotein d |
| 06/23/2004 | EP1430134A2 Hdv nucleic acid molecules, fragments and applications thereof |
| 06/23/2004 | EP1430133A2 A soluble toll-like receptor |
| 06/23/2004 | EP1430132A2 Methods of using 33751, a human potassium channel family member |
| 06/23/2004 | EP1430131A2 Muteins of human neutrophil gelatinase-associated lipocalin and related proteins |
| 06/23/2004 | EP1430130A2 Nucleic acid-associated proteins |
| 06/23/2004 | EP1430129A2 Asip-related proteins |
| 06/23/2004 | EP1430128A2 Micro-rna molecules |
| 06/23/2004 | EP1430127A1 Polynucleotide fragments of an infectious human endogenous retrovirus |
| 06/23/2004 | EP1430126A1 Dna sequences for human angiogenesis genes |
| 06/23/2004 | EP1430125A2 Sperm-specific cation channel, and uses therefor |
| 06/23/2004 | EP1430124A2 Artificial ubiquitous chromatin opening elements (ucoe) |
| 06/23/2004 | EP1430123A2 A method for generating hypermutable organisms |
| 06/23/2004 | EP1430122A2 Non-human animal model for analysis of the origin and therapy of organ fibrosis |
| 06/23/2004 | EP1430118A2 A gene encoding cyclododecanone monooxygenase |
| 06/23/2004 | EP1430116A2 A packaging complementation cell-line for sv-40 vectors |
| 06/23/2004 | EP1430115A1 Immortilized stem cells |
| 06/23/2004 | EP1430111A1 Culture system for rapid expansion of human embryonic stem cells |
| 06/23/2004 | EP1430110A2 Novel antibodies that bind to antigenic polypeptides, nucleic acids and encodingthe antigens, and methods of use. |
| 06/23/2004 | EP1430083A2 T1r taste receptors and genes encoding same |
| 06/23/2004 | EP1430079A1 Fluorescent proteins |
| 06/23/2004 | EP1430078A2 Method for increasing the solubility, expression rate and the activity of proteins during recombinant production |
| 06/23/2004 | EP1430077A2 Identification of cd8 epitopes from hiv-1 proteins for prevention and therapy of hiv infections |
| 06/23/2004 | EP1430076A2 Polypeptides derived from inducible hsp70 and pharmaceutical compositions containing the same |
| 06/23/2004 | EP1430072A2 Antisense modulation of cholesteryl ester transfer protein expression |
| 06/23/2004 | EP1430071A1 Secreted and cell surface genes expressed in benign and malignant colorectal tumors |
| 06/23/2004 | EP1430070A2 Novel clark protein and nucleic acid molecules and uses therefor |
| 06/23/2004 | EP1430069A2 Amplification and detection reagents for hiv-1 |
| 06/23/2004 | EP1429806A2 Extracellular massengers |
| 06/23/2004 | EP1429803A2 Anti-coronavirus vaccine |
| 06/23/2004 | EP1429799A2 Kgf polypeptide compositions |
| 06/23/2004 | EP1429797A2 Diagnosis and treatment of malignant neoplasms |
| 06/23/2004 | EP1429648A2 METHODS FOR SCREENING FOR SUBSTANCES WHICH INHIBIT FP PROSTANOID RECEPTOR INTERACTION WITH A COMPOUND HAVING PGF 2$g(a)alpha?ACTIVITY AND METHODS OF TREATING CANCER |
| 06/23/2004 | EP1429623A1 Delivery of disease control in aquaculture and agriculture using nutritional feeds containing bioactive proteins produced by viruses |
| 06/23/2004 | EP1429615A1 Oral vaccines |
| 06/23/2004 | EP1425411A4 Dna detector based on molecular controlled semiconductor resistor |
| 06/23/2004 | EP1397676A4 Use of duckweed in high throughput screening |
| 06/23/2004 | EP1390546A4 Biological sample processing methods and compositions that include surfactants |
| 06/23/2004 | EP1373885A4 Methods, platforms and kits useful for identifying, isolating and utilizing nucleotide sequences which regulate gene expression in an organism |
| 06/23/2004 | EP1342730A4 Fusion protein having the enhanced in vivo activity of erythropoietin |
| 06/23/2004 | EP1315795A4 Methods for imparting desirable phenotypic traits, including drought, freeze, and high salt tolerance and methods for increasing seed production |
| 06/23/2004 | EP1315410A4 Enhanced meristematic activity and competence by overexpression of tonoplast pyrophosphatase |
| 06/23/2004 | EP1311820A4 Increased separation efficiency via controlled aggregation of magnetic nanoparticles |
| 06/23/2004 | EP1282697A4 A construct capable of release in closed circular form from a larger nucleotide sequence permitting site specific expression and/or developmentally regulated expression of selected genetic sequences |
| 06/23/2004 | EP1268801B1 A method for in vitro molecular evolution of antibody function |
| 06/23/2004 | EP1263932A4 Embryonic stem cells and neural progenitor cells derived therefrom |
| 06/23/2004 | EP1254372B1 Binding acceleration techniques for the detection of analytes |
| 06/23/2004 | EP1208213B1 Method for production of proteins in host cells involving the use of chaperonins |
| 06/23/2004 | EP1180112A4 Detection using degradation of a tagged sequence |
| 06/23/2004 | EP1171573B1 Arpe-19 as a platform cell line for encapsulated cell-based delivery |
| 06/23/2004 | EP1131411B1 Suppression of xenotransplant rejection |
| 06/23/2004 | EP1068323B1 Recombinant major allergen of the pollen of artemisia vulgaris (mugwort) |
| 06/23/2004 | EP1032671B1 Mammalian cytokine-like polypeptide-10 |
| 06/23/2004 | EP0977861B1 Mammalian cytokine-like factor 7 |
| 06/23/2004 | EP0975802B1 Method of nucleic acid sequencing |
| 06/23/2004 | EP0973931A4 Process for processing sucrose into glucose and fructose |
| 06/23/2004 | EP0871471B1 Compositions using morphogenic proteins and stimulatory factors |
| 06/23/2004 | EP0854936A4 Method for characterizing nucleic acid molecules |
| 06/23/2004 | EP0796346A4 Nucleic acid sequence detection employing amplification probes |
| 06/23/2004 | EP0646176B1 Delivery and expression of a hybrid surface protein on the surface of gram positive bacteria |
| 06/23/2004 | EP0635051B1 Increasing the trehalose content of organisms by transforming them with combinations of the structural genes for trehalose synthase |